BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 7125737)

  • 1. Thyroid venous catheterization in the early diagnosis of familial medullary thyroid carcinoma.
    Wells SA; Baylin SB; Johnsrude IS; Harrington DP; Mendelsohn G; Ontjes DJ; Cooper CW
    Ann Surg; 1982 Nov; 196(5):505-11. PubMed ID: 7125737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medullary thyroid carcinoma: relationship of method of diagnosis to pathologic staging.
    Wells SA; Baylin SB; Gann DS; Farrell RE; Dilley WG; Preissig SH; Linehan WM; Cooper CW
    Ann Surg; 1978 Sep; 188(3):377-83. PubMed ID: 686900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of pentagastrin test for preoperative differential diagnosis between C-cell hyperplasia and medullary thyroid carcinoma in patients with moderately elevated basal calcitonin levels.
    Milone F; Ramundo V; Chiofalo MG; Severino R; Paciolla I; Pezzullo L; Lombardi G; Colao A; Faggiano A
    Clin Endocrinol (Oxf); 2010 Jul; 73(1):85-8. PubMed ID: 20039894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum calcitonin levels with calcium loading tests before and after total thyroidectomy in patients with thyroid diseases other than medullary thyroid carcinoma.
    Kudo T; Miyauchi A; Ito Y; Yabuta T; Inoue H; Higashiyama T; Tomoda C; Hirokawa M; Amino N
    Endocr J; 2011; 58(3):217-21. PubMed ID: 21358115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pentagastrin stimulation test and early diagnosis of medullary thyroid carcinoma using an immunoradiometric assay of calcitonin: comparison with genetic screening in hereditary medullary thyroid carcinoma.
    Barbot N; Calmettes C; Schuffenecker I; Saint-André JP; Franc B; Rohmer V; Jallet P; Bigorgne JC
    J Clin Endocrinol Metab; 1994 Jan; 78(1):114-20. PubMed ID: 7904611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial nonmultiple endocrine neoplasia medullary thyroid carcinoma: an evolving clinical entity.
    McHenry CR; Oppenheim DS; Murphy T; Broughan T; Vogt D; Goldfarb WB
    Surgery; 1992 Oct; 112(4):728-32; discussion 732-3. PubMed ID: 1411944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Provocative testing for occult medullary carcinoma of the thyroid: findings in seven children with multiple endocrine neoplasia type IIa.
    Graham SM; Genel M; Touloukian RJ; Barwick KW; Gertner JM; Torony C
    J Pediatr Surg; 1987 Jun; 22(6):501-3. PubMed ID: 2886576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of sporadic medullary thyroid carcinoma: the importance of routine measurement of serum calcitonin in the diagnostic evaluation of thyroid nodules.
    Rieu M; Lame MC; Richard A; Lissak B; Sambort B; Vuong-Ngoc P; Berrod JL; Fombeur JP
    Clin Endocrinol (Oxf); 1995 May; 42(5):453-60. PubMed ID: 7621562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can sporadic medullary thyroid carcinoma be biochemically predicted? Prospective analysis of 66 operated patients with elevated serum calcitonin levels.
    Iacobone M; Niccoli-Sire P; Sebag F; De Micco C; Henry JF
    World J Surg; 2002 Aug; 26(8):886-90. PubMed ID: 12016469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Provocative agents and the diagnosis of medullary carcinoma of the thyroid gland.
    Wells SA; Baylin SB; Linehan WM; Farrell RE; Cox EB; Cooper CW
    Ann Surg; 1978 Aug; 188(2):139-41. PubMed ID: 686877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules.
    Costante G; Meringolo D; Durante C; Bianchi D; Nocera M; Tumino S; Crocetti U; Attard M; Maranghi M; Torlontano M; Filetti S
    J Clin Endocrinol Metab; 2007 Feb; 92(2):450-5. PubMed ID: 17119000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcitonin concentrations in patients with chronic kidney disease and medullary thyroid carcinoma or c-cell hyperplasia.
    Borchhardt KA; Heinzl H; Gessl A; Hörl WH; Kaserer K; Sunder-Plassmann G
    Kidney Int; 2006 Dec; 70(11):2014-20. PubMed ID: 17051143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The importance of early diagnosis in patients with hereditary medullary thyroid carcinoma.
    Wells SA; Baylin SB; Leight GS; Dale JK; Dilley WG; Farndon JR
    Ann Surg; 1982 May; 195(5):595-9. PubMed ID: 7073356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma.
    Pacini F; Fontanelli M; Fugazzola L; Elisei R; Romei C; Di Coscio G; Miccoli P; Pinchera A
    J Clin Endocrinol Metab; 1994 Apr; 78(4):826-9. PubMed ID: 8157706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experience with a provocative test of calcitonin release as a prospective screening for preclinical medullary thyroid carcinoma in MEN type 2A family members.
    van Lathem JJ; Vermaak WJ; Kuyl JM; Mollentze W; Jansen S; Wolmarans L; Pelser H; Barry R; Kruger AJ; Wolfaardt M
    J Clin Lab Anal; 1992; 6(6):384-90. PubMed ID: 1359042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium infusion and pentagastrin injection in diagnosis of medullary thyroid carcinoma.
    Verdy M; Cholette JP; Cantin J; Lacroix A; Sturtridge WC
    Can Med Assoc J; 1978 Jul; 119(1):29-35. PubMed ID: 679097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basal and pentagastrin-stimulated calcitonin cut-off values in diagnosis of preoperative medullary thyroid cancer.
    Kartal Baykan E; Erdoğan M
    Turk J Med Sci; 2021 Apr; 51(2):650-656. PubMed ID: 33128357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medullary carcinoma of the thyroid. (Clinical and endocrinological features of six cases).
    degli Uberti EC; Trasforini G; Bagni B; Liboni A; Pansini GC; Altavilla G
    Ric Clin Lab; 1981; 11(2):171-8. PubMed ID: 7268276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of occult metastases of medullary thyroid carcinoma by pentagastrin-stimulated intravenous calcitonin sampling followed by targeted surgery.
    Schott M; Willenberg HS; Sagert C; Nguyen TB; Schinner S; Cohnen M; Cupisti K; Eisenberger CF; Knoefel WT; Scherbaum WA
    Clin Endocrinol (Oxf); 2007 Mar; 66(3):405-9. PubMed ID: 17302876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromogranin A as tumor marker in medullary thyroid carcinoma.
    Blind E; Schmidt-Gayk H; Sinn HP; O'Connor DT; Raue F
    Thyroid; 1992; 2(1):5-10. PubMed ID: 1356053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.